Rumored Buzz on Healthcare News
FTC sues significant pharmacy benefit managers above insulin costs The agency introduced action in opposition to Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating procedures “artificially inflated” the checklist price of everyday living-conserving insulin medications.Exactly where are each of the